Nurse Practitioner, Family · San Francisco, CA
NPI
1336822519
Since 2023
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1825 4th St
San Francisco, CA, 94143
Phone (415) 353-9888
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.1M
1,027 prescriptions
Company payments, 2025
$448
From 13 companies
Medicare prescription drug claims, 2024
In 2024, the drug Michelle J Russell prescribed most often to Medicare patients was Prochlorperazine Maleate, with 78 prescriptions and refills. In total Michelle J Russell wrote 1,027 Medicare prescriptions that cost $2.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prochlorperazine Maleate Generic | 78 | 78 | 52 | $1,020 |
| Leucovorin Calcium Generic | 63 | 63 | Under 11 | $9,742 |
| Ondansetron Hcl Generic | 56 | 57 | 47 | $1,740 |
| Oxaliplatin Generic | 52 | 52 | Under 11 | $1,872 |
| Palonosetron Hcl Generic | 48 | 48 | 15 | $1,621 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 32 | 32 | Under 11 | $196K |
| Neulasta Onpro Pegfilgrastim | 29 | 29 | Under 11 | $180K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 28 | 52 | Under 11 | $132 |
| Aranesp Darbepoetin Alfa In Polysorbat | 27 | 27 | 13 | $51K |
| Acyclovir Generic | 25 | 31 | Under 11 | $258 |
| Eliquis Apixaban | 24 | 26 | Under 11 | $15K |
| Dexamethasone Generic | 21 | 29 | 15 | $444 |
| Docetaxel Generic | 20 | 20 | Under 11 | $5,115 |
| Xgeva Denosumab | 19 | 19 | Under 11 | $58K |
| Opdivo Nivolumab | 18 | 18 | Under 11 | $157K |
Brand drugs: 383 claims; generic drugs: 644 claims; opioid claims: 49.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle J Russell $448 ($448 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $55.68.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $55.68 |
| Daiichi Sankyo Inc. 4568.T | 2 | $50.41 |
| Janssen Biotech, Inc. JNJ | 2 | $48.02 |
| Taiho Oncology, Inc. 4578.T | 1 | $40.7 |
| Geron Corporation GERN | 1 | $35.95 |
| Merck Sharp & Dohme LLC MRK | 1 | $33.35 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $30.93 |
| Deciphera Pharmaceuticals Inc. | 1 | $30.12 |
| Pfizer Inc. PFE | 1 | $29.38 |
| Legend Biotech USA Inc. LEGN | 1 | $27.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.